3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
74
Colorectal Neoplasms
43
Rectal Neoplasms
42
Stomach Neoplasms
39
Triple Negative Breast Neoplasms
31
Neoplasm Metastasis
20
Esophageal Neoplasms
16
Colonic Neoplasms
16
Neoplasms
14
Pancreatic Neoplasms
12
Parkinson Disease 4, Autosomal Dominant Lewy Body
11
Nasopharyngeal Carcinoma
11
Adenocarcinoma
11
Biliary Tract Neoplasms
10
Adenocarcinoma Of Esophagus
9
Cholangiocarcinoma
7
Locally Advanced Rectal Cancer
6
Esophageal Squamous Cell Carcinoma
6
Brain Neoplasms
6
Anus Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Recurrence
5
Neuroendocrine Tumors
5
Gastrointestinal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Ovarian Neoplasms
4
HER2-positive Breast Cancer
4
Colorectal Cancer Metastatic
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumors
4
Interventions
zimberelimab
1
pembrolizumab
1
olaparib
1
lutetium Lu 177 dotatate
1
lanreotide
1
fluorodopa F 18
1
cabozantinib
1
Sunitinib
1
Random Allocation
1
Octreotide
1
Nivolumab
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoid Tumor
×
Capecitabine
×
1 year
×
Clear all
No trials found.